HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Penehyclidine hydrochloride ameliorates renal ischemia-reperfusion injury in rats.

AbstractBACKGROUND:
Renal ischemia-reperfusion (I/R) injury is a major cause of acute kidney failure by mechanisms that involve oxidative stress, inflammation, and apoptosis. Penehyclidine hydrochloride (PHC), a selective anticholinergic agent, possesses anti-inflammatory, antioxidative stress, and antiapoptotic effects. Therefore, we investigated the ability of PHC to ameliorate renal I/R injury in Sprague-Dawley rats.
MATERIALS AND METHODS:
Rats were randomly assigned to three groups (35 rats per group): sham operated, saline-treated I/R, and PHC-treated I/R. After removing the right kidney, renal I/R injury was induced by clamping the left renal artery for 45 min followed by reperfusion. The rats were administered PHC (0.45 mg/kg, intravenously) or saline 30 min before renal ischemia. The blood and kidneys were harvested at 1, 3, 6, 12, or 24 h after reperfusion. Renal function and histologic changes were assessed. Markers of oxidative stress, inflammation, and apoptosis in the kidneys were also measured.
RESULTS:
PHC treatment significantly attenuated renal dysfunction and histologic damage caused by I/R injury. The treatment also decreased malondialdehyde level and attenuated the reduction in superoxide dismutase activity in the kidney. Moreover, the levels of activated p38 mitogen-activated protein kinase, nuclear factor kappa B, and caspase 3 were lower in the PHC-treated animals.
CONCLUSIONS:
PHC protected rat kidneys from I/R injury by attenuating oxidative stress, inflammatory response, and apoptosis. Thus, PHC may represent a novel practical strategy for the treatment of renal I/R injury.
AuthorsYun-peng Wang, Gang Li, Lu-lin Ma, Yi Zheng, Shu-dong Zhang, Hong-xian Zhang, Min Qiu, Xin Ma
JournalThe Journal of surgical research (J Surg Res) Vol. 186 Issue 1 Pg. 390-7 (Jan 2014) ISSN: 1095-8673 [Electronic] United States
PMID23972620 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier Inc. All rights reserved.
Chemical References
  • Cholinergic Antagonists
  • Quinuclidines
  • Transcription Factor RelA
  • penehyclidine
  • Malondialdehyde
  • Superoxide Dismutase
  • p38 Mitogen-Activated Protein Kinases
  • Caspase 3
Topics
  • Animals
  • Caspase 3 (analysis)
  • Cholinergic Antagonists (therapeutic use)
  • Kidney (blood supply)
  • Male
  • Malondialdehyde (analysis)
  • Oxidative Stress
  • Quinuclidines (therapeutic use)
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury (drug therapy, metabolism)
  • Superoxide Dismutase (metabolism)
  • Transcription Factor RelA (analysis)
  • p38 Mitogen-Activated Protein Kinases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: